Research output per year
Research output per year
Fingerprint
Dive into the research topics where Waldman Department of Dermatology is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
Research output
-
52-Week Safety and Efficacy of Amlitelimab in Participants With Moderate-to-Severe Atopic Dermatitis: Preliminary Analysis From the Open-Label Long-Term ATLANTIS Trial
Guttman-Yassky, E., Magnolo, N., Sauder, M., Staumont-Sallé, D., Igawa, K., Ameen, M., Ma, L., Ackerman, L., Gherardi, G., Li, P., Espinasse, M., Yen, K. & Bernigaud, C., May 2026, In: SKIN: Journal of Cutaneous Medicine. 10, 3, p. s780Research output: Contribution to journal › Article › peer-review
Open Access -
Absolute Eczema Area and Severity Index Responses with Lebrikizumab in Patients with Moderate-to-severe Atopic Dermatitis: A Secondary Analysis of Two Phase 3 Trials
Thaçi, D., Puig, L., Motegi, S. I., Papp, K., Stein Gold, L., Kircik, L., Sofen, H., Fernández-Peñas, P., Herranz, P., Vestergaard, C., Huang, Y. H., Dossenbach, M., Elmaraghy, H., Gallo, G., Rueda, M. J., Casillas, M., Yang, C., Agell, H., Falqués, M. & Nosbaum, A., 2026, In: Acta Dermato-Venereologica. 106, adv-2025-0160.Research output: Contribution to journal › Article › peer-review
Open Access -
A Dermatologist’s Perspective on Cutaneous Adverse Effects in CTCAE Version 6.0
Gulati, N., Block, B. R., Mehta, J. & Marron, T. U., 2026, (Accepted/In press) In: JAMA Oncology.Research output: Contribution to journal › Short survey › peer-review
-
Advanced Topical Nonsteroidal Therapies for Atopic Dermatitis: Consensus Statements From an Expert Panel
Armstrong, A. W., Nong, Y., Bunick, C. G., Chovatiya, R., Hebert, A. A., Kircik, L., Yu, J. & Lebwohl, M. G., Mar 2026, In: Journal of Drugs in Dermatology. 25, 3, p. 221-227 7 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Advances in Gentle Polymeric Cleansing Technologies
Draelos, Z., Zeichner, J., Miller, D., Li, W. H., Hussain, R., Wolff, K., Parsa, R. & Tierney, N. K., May 2026, In: Journal of Drugs in Dermatology. 25, 5, p. 465-470 6 p.Research output: Contribution to journal › Article › peer-review
-
Aesthetic Concerns and Nonsurgical Treatment Trends in Patients With GLP-1 Agonist–Associated Weight Loss
Fabi, S., Yoo, J., Kaufman-Janette, J., Dayan, S., Boyd, C., Sangha, S. & Ashourian, N., Jun 2026, In: Dermatologic Surgery. 52, 6SResearch output: Contribution to journal › Article › peer-review
-
A gated hydrophobic funnel within BAX binds bioactive lipids to potentiate pro-apoptotic function
Gelles, J. D., Chen, Y., Luna-Vargas, M. P. A., Viacava Follis, A., Al Noman, M. A., Kabir, M., Bayiokos, S. G., Mohammed, J. N., Sebastian, T. M., Pham, N. D., Shi, Y., Jin, J., Kriwacki, R. W. & Chipuk, J. E., Dec 2026, In: Nature Communications. 17, 1, 3180.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
AI-Assisted Billing in Dermatologic Surgery: Evaluating ChatGPT's and Gemini's Accuracy in CPT Code Assignment
Modiri, O., Ebriani, J., Jairath, N. & Lewin, J., Jan 2026, In: Dermatologic Surgery. 52, 1, p. 98-100 3 p.Research output: Contribution to journal › Letter › peer-review
1 Scopus citations -
Alopecia areata: A clinical review of the changing landscape with Janus kinase inhibitors
Lebwohl, M. G., Lain, E. L., McMichael, A., Senna, M. M. & Mesinkovska, N. A., Mar 2026, In: JAAD Reviews. 7, p. 1-8 8 p.Research output: Contribution to journal › Review article › peer-review
Open Access1 Scopus citations -
Alopecia Areata and Atopic Dermatitis: Common Mechanisms and Emerging Therapeutics
Tang, A., Rachko, G., Manzo Margiotta, F., Levine, J., Del Duca, E. & Ungar, B., 2026, In: Journal of Inflammation Research. 19, 549496.Research output: Contribution to journal › Review article › peer-review
Open Access -
AMCP Market Insights: Beyond skin deep on the role of managed care in moderate to severe atopic dermatitis
Flavin, B., Wolff, D., Abdo, M., Adeboye, A., Chitre, M., Contreras, Z., Gandhi, G., Lebwohl, M., Richardson, T. & Smith Begolka, W., 1 May 2026, In: Journal of Managed Care and Specialty Pharmacy. 32, 5-b, p. S1-S9Research output: Contribution to journal › Article › peer-review
-
A multidisciplinary Delphi consensus on the modern definition of pruritus: Sensation and disease
Ständer, S., Schmelz, M., Lerner, E., Murota, H., Nattkemper, L., Reich, A., Stahl, L. S., Yosipovitch, G., Weisshaar, E., Wiegmann, H., Apfelbacher, C. & Kim, B. S., Jan 2026, In: Journal of the European Academy of Dermatology and Venereology. 40, 1, p. 59-66 8 p.Research output: Contribution to journal › Article › peer-review
Open Access17 Scopus citations
Press/Media
-
Takeda's Zasocitinib Demonstrates Consistent, High Rates of Skin Clearance Across the Body, Including Hard-to-Treat and High-Impact Sites, in Phase 3 Psoriasis Studies
16/07/26 → 18/07/26
28 items of Media coverage
Press/Media
-
Eli Lilly & Co. (NYSE:LLY) drifts lower 0.8% in Week 28 of 2026: Latest News and Company Communication
17/07/26
1 item of Media coverage
Press/Media
-
Takeda unveils secondary endpoint data from Phase III PsO pill trials
17/07/26
2 items of Media coverage
Press/Media
-
Takeda’s Zasocitinib Shows High Skin-Clearance Rates Across Hard-to-Treat Psoriasis Sites
17/07/26
1 item of Media coverage
Press/Media
-
Zasocitinib: High Rates of Clearance for Scalp, Nail, Palmoplantar PsO
17/07/26
1 item of Media coverage
Press/Media
-
-
Your Hair Keeps Breaking and You Can’t Figure Out Why? These 30 Invisible Mistakes Are Probably to Blame
16/07/26
1 item of Media coverage
Press/Media
-
Zasocitinib Demonstrates Strong Week 16 Responses Across High-Impact Psoriasis …
16/07/26
1 item of Media coverage
Press/Media
-